awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41418443-BC18F60E-245A-4811-A2C0-6F87A4FA0C69
Q41418443-BC18F60E-245A-4811-A2C0-6F87A4FA0C69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418443-BC18F60E-245A-4811-A2C0-6F87A4FA0C69
MET expression during prostate cancer progression.
P2860
Q41418443-BC18F60E-245A-4811-A2C0-6F87A4FA0C69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418443-BC18F60E-245A-4811-A2C0-6F87A4FA0C69
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c326d2aaa9c43efd18cebc23ee186f95f369b0ab
P2860
Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.